3
Announcements
Trials
Browse
Landscape
Status
Recruiting
47
Active not recruiting
27
Not yet recruiting
19
Completed
10
Withdrawn
4
Suspended
2
Enrolling by invitation
2
Terminated
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Plasma cell
1
Genitourinary
1
Conditions
Neoplasms
33
Breast Neoplasms
17
Prostatic Neoplasms
15
Colorectal Neoplasms
13
Hematologic Neoplasms
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Lung Neoplasms
6
Stomach Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Lymphoma, Non-Hodgkin
5
Leukemia, Myeloid, Acute
5
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Myasthenia Gravis
4
Melanoma
4
Lymphoma
4
Head and Neck Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Adenocarcinoma
4
Pain
3
Ovarian Neoplasms
3
Neoplasm Metastasis
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia
3
Hematopoietic and Lymphatic System Neoplasm
3
Hematologic Diseases
3
Glioma
3
Gastrointestinal Neoplasms
3
Disease
3
Colonic Neoplasms
3
Interventions
Inosine Monophosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Lymphoma, B-Cell
×
90 days
×
Clear all
NCT07474051
2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
178 enrolled
NCT05332054
2026-03-12
LTFS
Caribou Biosciences, Inc.
Enrolling by invitation
150 enrolled